en directe

Creatio takes part in the production of CAR-T ARI-0001 advanced therapy

5 March, 2021
Master number
Icona descarregar Download
Icona notificar Notify

Creatio, the Production and Validation Center for Advanced Therapies of the University of Barcelona, has taken part in the production of viruses that act as vectors for the CAR-T ARI-0001 drug, approved by the Spanish Agency of Medicines and Medical Devices (AEMPS) and carried out by the Hospital Clínic de Barcelona.


Llicència Creative Commons by-nc-nd
© Unitat de Producció Audiovisual